MDXH Competitors & Alternatives
Compare MDxHealth SA ADR with similar stocks in the same industry
Diagnostics & Research
MDXH
Main Stock$0.55
Tradestie Score
45
Market Cap
$231.40M
Revenue Growth
0.0%
Analyst Upside
+228.5%
Top Competitors
39 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NEO
NeoGenomics, Inc.
|
$19.29
|
$1.13B | - | 30 | Compare |
|
CDNA
CareDx, Inc.
|
$64.60
|
$798.40M | 30.6 | 36 | Compare |
|
FLGT
Fulgent Genetics, Inc. Common Stock
|
$22.36
|
$719.31M | - | 42 | Compare |
|
CSTL
Castle Biosciences, Inc. Common Stock
|
$35.93
|
$667.77M | - | 32 | Compare |
|
PSNL
Personalis, Inc. Common Stock
|
$16.32
|
$612.76M | - | 51 | Compare |
|
NYXH
Nyxoah SA Ordinary Shares
|
$1.59
|
$185.47M | - | 42 | Compare |
|
SERA
Sera Prognostics, Inc. Class A Common Stock
|
$2.02
|
$112.28M | - | 53 | Compare |
|
LUCD
Lucid Diagnostics Inc. Common Stock
|
$0.81
|
$103.93M | - | 52 | Compare |
|
BDSX
Biodesix, Inc. Common Stock
|
$30.42
|
$61.36M | - | 36 | Compare |
|
DRMA
Dermata Therapeutics, Inc. Common Stock
|
$1.12
|
$3.50M | - | 65 | Compare |
More MDXH Analysis
Data updated: Sep 28, 2026 | Industry: Diagnostics & Research (SIC 8071)
39 stocks in this industry